Sponsor content
59 result(s) found, displaying 21 to 30
-
Prescription medicine decision summaryRelfydess (relabotulinumtoxinA, purified Botulinum toxin type A) has been approved for the temporary improvement in the appearance of glabellar lines ("frown lines") and lateral canthal lines ("crows feet").
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Prescription medicine decision summarySohonos (palovarotene) is approved to reduce the formation of heterotopic ossification.
-
-
FORLAX macrogol 4000 10g powder for oral solution sachet Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Ipsen Pty Ltd -
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.